NCT02426866View on ClinicalTrials.gov

Risk of CV Events With EFV vs. EFV-free Regimens

CompletedOBSERVATIONAL
Enrollment

29,612

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
HIV/AIDS
Interventions
DRUG

Efavirenz

Sponsors
All Listed Sponsors
collaborator

Truven health

UNKNOWN

lead

Bristol-Myers Squibb

INDUSTRY